Molecular markers of phenotype, therapeutic responsiveness and prognosis in human cancers. [ 2009 - 2013 ]

Also known as: Improving characterisation of human cancers in order to optimise clinical management and treatment

Research Grant

[Cite as]

Researchers: Prof Roger Daly (Principal investigator) ,  Prof Andrew Biankin A/Pr Ewan Millar Prof Elizabeth Musgrove Prof Christopher Ormandy
View all 9 related researchers

Brief description This proposal aims to identify molecular markers that can be used to classify subtypes of particular cancers according to their prognosis and response to therapy. This will optimise selection of patients for the most appropriate treatment and lead to the development of new therapeutic strategies.

Funding Amount $AUD 11,762,116.79

Funding Scheme Programs

Notes Program Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]